Patents by Inventor Jennifer L. Hillman

Jennifer L. Hillman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMAN CARBOHYDRATE METABOLISM ENZYMES
    Publication number: 20020061301
    Abstract: The invention provides human carbohydrate metabolism enzymes (CARM) and polynucleotides which identify and encode CARM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of CARM.
    Type: Application
    Filed: May 15, 1998
    Publication date: May 23, 2002
    Inventors: OLGA BANDMAN, JENNIFER L. HILLMAN, PREETI LAL, KARL J. GUEGLER, GINA GORGONE, NEIL C. CORLEY, CHANDRA PATTERSON, MARIAH R. BAUGHN
  • Ras proteins
    Patent number: 6391580
    Abstract: The invention provides seven human Ras proteins (RASP) and polynucleotides which identify and encode RASP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of RASP.
    Type: Grant
    Filed: May 8, 1998
    Date of Patent: May 21, 2002
    Assignee: Incyte Genomics, Inc.
    Inventors: Jennifer L. Hillman, Y. Tom Tang, Preeti Lal, Karl J. Guegler, Neil C. Corley, Chandra Patterson, Sajeev Batra, Mariah R. Baughn
  • Human regulatory molecules
    Publication number: 20020058264
    Abstract: The invention provides human regulatory molecules and the polynucleotides which identify and encode them. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention further provides methods for diagnosing and treating disorders associated with expression of human regulatory molecules.
    Type: Application
    Filed: September 26, 2001
    Publication date: May 16, 2002
    Applicant: Incyte Pharmaceuticals, Inc
    Inventors: Preeti Lal, Jennifer L. Hillman, Olga Bandman, Purvi Shah, Janice Au-Young, Henry Yue, Karl J. Guegler, Neil C. Corley
  • Human serine carboxypeptidase
    Patent number: 6379913
    Abstract: The present invention provides a human serine carboxypeptidase (CPEPT) and polynucleotides which identify and encode CPEPT. The invention also provides expression vectors, host cells, agonists, antibodies, and antagonists. The invention also provides methods for treating disorders associated with expression of CPEPT.
    Type: Grant
    Filed: April 26, 1999
    Date of Patent: April 30, 2002
    Assignee: Incyte Genomics, Inc.
    Inventors: Olga Bandman, Phillip R. Hawkins, Jennifer L. Hillman, Preeti Lal, Surya K. Goli
  • CAF1-related protein
    Patent number: 6376651
    Abstract: The invention provides a human CAF1-related protein (CAFRP) and polynucleotides which identify and encode CAFRP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of CAFRP.
    Type: Grant
    Filed: June 25, 1999
    Date of Patent: April 23, 2002
    Assignee: Incyte Genomics, Inc.
    Inventors: Jennifer L. Hillman, Neil C. Corley, Henry Yue
  • Glutathione S-transferase homolog
    Patent number: 6368810
    Abstract: The invention provides a human glutathione S-transferase (GSTH) and polynucleotides which identify and encode GSTH. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating and preventing disorders associated with expression of GSTH.
    Type: Grant
    Filed: April 16, 1999
    Date of Patent: April 9, 2002
    Assignee: Incyte Genomics, Inc.
    Inventors: Jennifer L. Hillman, Neil C. Corley, Purvi Shah
  • Ndr2-related proteins
    Publication number: 20020039731
    Abstract: The invention provides cDNA which encode Ndr2-related proteins. It also provides for the use of the cDNAs, fragments, complements, and variants thereof and of the encoded proteins, portions thereof and antibodies thereto for diagnosis and treatment of cancer, particularly cancers of the intestine, breast, uterus, liver, brain, and kidney. The invention additionally provides expression vectors and host cells for the production of the proteins and a transgenic model system.
    Type: Application
    Filed: March 19, 2001
    Publication date: April 4, 2002
    Inventors: Susan G. Stuart, Janice Au-Young, Jennifer L. Hillman, Purvi Shah, Henry Yue
  • Translational regulator
    Patent number: 6365714
    Abstract: The invention provides a human translational regulator (TRANAC) and polynucleotides which identify and encode TRANAC. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of TRANAC.
    Type: Grant
    Filed: December 17, 1998
    Date of Patent: April 2, 2002
    Assignee: Incyte Genomics, Inc.
    Inventors: Jennifer L. Hillman, Phillip R. Hawkins
  • Ubiquitin-like conjugating protein
    Patent number: 6365358
    Abstract: The invention provides a human ubiquitin-like conjugating protein (UBCLE) and polynucleotides which identify and encode UBCLE. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of UBCLE.
    Type: Grant
    Filed: June 9, 1999
    Date of Patent: April 2, 2002
    Assignee: Incyte Genomics, Inc.
    Inventors: Jennifer L. Hillman, Purvi Shah, Neil C. Corley
  • Novel tumorigenesis protein
    Publication number: 20020037518
    Abstract: The present invention provides a human tumorigenesis protein (HTAP) and polynucleotides which identify and encode HTAP. In addition, the invention provides expression vectors and host cells, agonists, antibodies, and antagonists. The invention also provides methods for producing HTAP and for treating or preventing disorders associated with the expression of HTAP.
    Type: Application
    Filed: May 4, 2001
    Publication date: March 28, 2002
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Jennifer L. Hillman, Surya K. Goli
  • Project-based full-length biomolecular sequence database with expression categories
    Patent number: 6363399
    Abstract: Disclosed is a relational database system for storing biomolecular sequence information in a manner that allows sequences to be catalogued and searched according to association with one or more projects for obtaining full-length biomolecular sequences from shorter sequences. The relational database has sequence records containing information identifying one or more projects to which each of the sequence records belong. Each project groups together one or more biomolecular sequences generated during work to obtain a full-length gene sequence from a shorter sequence. The computer system has a user interface allowing a user to selectively view information regarding one or more projects. The relational database also provides interfaces and methods for accessing and manipulating and analyzing project-based information.
    Type: Grant
    Filed: January 3, 2001
    Date of Patent: March 26, 2002
    Assignee: Incyte Genomics, Inc.
    Inventors: Timothy J. Maslyn, Janice Au-Young, Jennifer L. Hillman, Harold Hibbert, Ingrid E. Akerblom, Rachel J. Cheng, Yuanhua T. Tang
  • NOVEL ATPASE INHIBITOR
    Publication number: 20020034510
    Abstract: The invention provides a novel human ATPase inhibitor protein (HATPI) and polynucleotides which identify and encode HATPI. The invention also provides genetically engineered expression vectors and host cells containing the nucleic acid sequences encoding HATPI. The invention also provides pharmaceutical compositions containing HATPI or antagonists to HATPI, and in the use of these compositions for the treatment of diseases associated with the expression of HATPI. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding HATPI for the treatment of diseases associated with the expression of HATPI. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, to hybridize to the genomic sequence or transcripts of polynucleotides encoding HATPI or anti-HATPI antibodies which specifically bind to HATPI.
    Type: Application
    Filed: March 19, 1999
    Publication date: March 21, 2002
    Inventor: JENNIFER L. HILLMAN
  • NOVEL REGULATOR OF CELL SIGNALING
    Publication number: 20020034777
    Abstract: The present invention provides a human reguslator of G-protein signaling (HRGS) and polynucleotides which identify and encode HRGS. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding HRGS and a method for producing HRGS. The invention also provides for agonists, antibodies, or antagonists specifically binding HRGS, and their use, in the prevention and treatment of diseases associated with expression of HRGS. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding HRGS for the treatment of diseases associated with the expression of HRGS. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding HRGS.
    Type: Application
    Filed: December 7, 1998
    Publication date: March 21, 2002
    Inventors: JENNIFER L. HILLMAN, SURYA GOLI
  • Human glutathione peroxidase-6
    Publication number: 20020031506
    Abstract: The invention provides a human glutathione peroxidase (GPx6) and polynucleotides which identify and encode GPx6. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of GPx6.
    Type: Application
    Filed: March 16, 2001
    Publication date: March 14, 2002
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Jennifer L. Hillman, Neil C. Corley, Chandra Patterson
  • RAS-LIKE PROTEIN
    Publication number: 20020025930
    Abstract: The present invention provides a human Ras-like protein (RLP) and polynucleotides which identify and encode RLP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. In addition, the invention provides methods for producing RLP and for treating or preventing disorders associated with expression of RLP.
    Type: Application
    Filed: November 23, 1998
    Publication date: February 28, 2002
    Inventors: JENNIFER L. HILLMAN, SURYA K. GOLI, NEIL C. CORLEY
  • Human cornichon molecule
    Patent number: 6348576
    Abstract: The invention provides a human cornichon protein (CORN) and polynucleotides which identify and encode CORN. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating and preventing disorders associated with expression of CORN.
    Type: Grant
    Filed: August 2, 1999
    Date of Patent: February 19, 2002
    Assignee: Incyte Genomics, Inc.
    Inventors: Jennifer L. Hillman, Neil C. Corley, Purvi Shah
  • NOVEL SUBUNITS OF NADH DEHYDROGENASE
    Publication number: 20020012983
    Abstract: The present invention provides four NADH dehydrogenase subunits (designated individually as NDS-1, NDS-2, NDS-3, and NDS-4 and collectively as NDS) and polynucleotides which identify and encode NDS. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding NDS and a method for producing NDS. The invention also provides for use of NDS and agonists, antibodies, or antagonists specifically binding NDS, in the prevention and treatment of diseases associated with expression of NDS. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding NDS for the treatment of diseases associated with the expression of NDS. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding NDS.
    Type: Application
    Filed: September 10, 1998
    Publication date: January 31, 2002
    Inventors: OLGA BANDMAN, SURYA K. GOLI, JENNIFER L. HILLMAN
  • Human citrate synthase homolog
    Patent number: 6323328
    Abstract: The invention provides a human citrate synthase homolog (HUCS) and polynucleotides which identify and encode HUCS. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of HUCS.
    Type: Grant
    Filed: November 13, 1997
    Date of Patent: November 27, 2001
    Assignee: Incyte Genomics, Inc.
    Inventors: Jennifer L. Hillman, Preeti Lal, Neil C. Corley, Purvi Shah
  • Human lysophospholipase
    Patent number: 6319701
    Abstract: The present invention provides a human lysophospholipase (NHLP) and polynucleotides which identify and encode NHLP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. In addition, the invention provides methods for producing NHLP and for treating or preventing disorders associated with expression of NHLP.
    Type: Grant
    Filed: December 15, 1998
    Date of Patent: November 20, 2001
    Assignee: Incyte Genomics, Inc.
    Inventors: Jennifer L. Hillman, Purvi Shah, Lynn E. Murry
  • Novel subunits of NADH dehydrogenase
    Publication number: 20010041356
    Abstract: The present invention provides four NADH dehydrogenase subunits (designated individually as NDS-1, NDS-2, NDS-3, and NDS-4 and collectively as NDS) and polynucleotides which identify and encode NDS. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding NDS and a method for producing NDS. The invention also provides for use of NDS and agonists, antibodies, or antagonists specifically binding NDS, in the prevention and treatment of diseases associated with expression of NDS. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding NDS for the treatment of diseases associated with the expression of NDS. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding NDS.
    Type: Application
    Filed: November 29, 2000
    Publication date: November 15, 2001
    Applicant: Incyte Pharmaceuticals, Inc
    Inventors: Olga Bandman, Surya K. Goli, Jennifer L. Hillman